ACCF/HRS/AHA/ASE/HFSA/SCAI/SCCT/SCMR

Similar documents
Automatic External Defibrillators

Cardiovascular Guidelines for DOT Physical Exams By Maureen Collins MSN, APRN, BC

Updated Cardiac Resynchronization Therapy Guidelines

Appropriate Use Criteria for ICD/CRT Online Appendix Guideline Mapping and References Document

Diagnostic and Therapeutic Procedures

Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death. Management of Patients With. Learn and Live SM. ACC/AHA/ESC Pocket Guideline

Cardiac Implants: Morgan, Lewis & Bockius, LLP. Scott A. Memmott Albert W. Shay. The New Enforcement Priority

IHE Cardiology (CARD) White Paper. Cardiac Electrophysiology Key Data Elements

2015 Billing and Coding Guide. Rhythm Management

ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death

Diagnosis Code Crosswalk : ICD-9-CM to ICD-10-CM Cardiac Rhythm and Heart Failure Diagnoses

Provider Checklist-Outpatient Imaging. Checklist: Nuclear Stress Test, Thallium/Technetium/Sestamibi (CPT Code )

Post-MI Cardiac Rehabilitation. Mark Mason Consultant Cardiologist Harefield Hospital Royal Brompton and Harefield NHS Foundation Trust

NCDR ICD Registry V2.1 Data Collection Form Generator & Leads

Premature Ventricular Contractions. Ralph Augostini, MD FACC FHRS

Medtronic Cardiac Rhythm and Heart Failure ICD-10 Coding for Physicians

GuidePoint. Physician Reimbursement Primer for Cardiac Rhythm Management. With Clinical Case Examples. GuidePoint is simplifying reimbursement.

Medical management of CHF: A New Class of Medication. Al Timothy, M.D. Cardiovascular Institute of the South

UPMC HEALTH PLAN MANAGEMENT OF HEART FAILURE WITH LEFT VENTRICULAR SYSTOLIC DYSFUNCTION: CLINICAL PRACTICE GUIDELINE

When to Implant an ICD and Which One. Brad Suprenant DO, FACC, FACOI

Billing and Coding Guide

Potential Causes of Sudden Cardiac Arrest in Children

Michael Hartman, CRNA, DNP, MSN, BSN, BA

NAME OF THE HOSPITAL: 1. Coronary Balloon Angioplasty: M7F1.1/ Angioplasty with Stent(PTCA with Stent): M7F1.3

NCDR ICD Registry V2.1 Coder's Data Dictionary

Heart Failure Outpatient Clinical Pathway

CARDIAC RISKS OF NON CARDIAC SURGERY

BASIC STANDARDS FOR RESIDENCY TRAINING IN CARDIOLOGY

Perioperative Cardiac Evaluation

6/5/2014. Objectives. Acute Coronary Syndromes. Epidemiology. Epidemiology. Epidemiology and Health Care Impact Pathophysiology

Introduction to Electrophysiology. Wm. W. Barrington, MD, FACC University of Pittsburgh Medical Center

Cardiology ARCP Decision Aid August 2014

National Imaging Associates, Inc. Clinical guidelines

COVERAGE GUIDANCE: ABLATION FOR ATRIAL FIBRILLATION

Cardiac Rehab. Home. Do you suffer from a cardiac condition that is limiting your independence in household mobility?

MADIT-II CLINICAL SUMMARY

UnitedHealthcare, UnitedHealthcare of the River Valley and Neighborhood Health Partnership Cardiology Notification and Prior Authorization Program:

Rome, Italy December 4-7, 2012 Rome Cavalieri TIMETABLE

Appendix. Costing Case Samples for OOHCA

1p36 and the Heart. John Lynn Jefferies, MD, MPH, FACC, FAHA

MEDICAL POLICY. 03/17/16 CATEGORY: Technology Assessment

MISSING DATA ANALYSIS AMONG PATIENTS IN THE PINNACLE REGISTRY

PVC s / PAC s What Do They Mean? What Should You Do? Jeffrey H. Neuhauser, D.O.,F.A.C.C. BHHI Primary Care Symposium February 27, 2015

Universitätsklinik für Kardiologie. Test. Thomas M. Suter Akute Herzinsuffizienz Diagnostik und Therapie 1

Specific Basic Standards for Osteopathic Fellowship Training in Cardiology

Cardiology ICD-10-CM Coding Tip Sheet Overview of Key Chapter Updates for Cardiology

Protocol. Cardiac Rehabilitation in the Outpatient Setting

Preparing for ICD-10 for Physicians

Coding Updates for 2013: Cardiology

Utilizing the Cath Lab for Cardiac Arrest

Atrial Fibrillation and Cardiac Device Therapy RAKESH LATCHAMSETTY, MD DIVISION OF ELECTROPHYSIOLOGY UNIVERSITY OF MICHIGAN HOSPITAL ANN ARBOR, MI

CANADIAN COUNCIL OF MOTOR TRANSPORT ADMINISTRATORS CONSEIL CANADIEN DES ADMINISTRATEURS EN TRANSPORT MOTORISÉ CCMTA MEDICAL STANDARDS FOR DRIVERS

CARDIAC ELECTROPHYSIOLOGY, ARRHYTHMIAS AND PACING. Medical Knowledge. Goals and Objectives PF EF MF LF Aspirational

Cardioverter defibrillator therapy in the primary and secondary prevention of sudden cardiac death

GUIDELINE 11.9 MANAGING ACUTE DYSRHYTHMIAS. (To be read in conjunction with Guideline 11.7 Post-Resuscitation Therapy in Adult Advanced Life Support)

Diana Heiman, MD Associate Professor, Family Medicine Residency Director East Tennessee State University

Signal-averaged electrocardiography late potentials

Safety, Efficacy, and Performance of Implanted Recycled Cardiac Rhythm Management (CRM) Devices in Underprivileged Patients

on behalf of the AUGMENT-HF Investigators

ATRIAL FIBRILLATION (RATE VS RHYTHM CONTROL)

California Health and Safety Code, Section

EHRA/HRS/APHRS expert consensus on ventricular arrhythmias

Life Threatening EKG s In The Office. Joseph A Manfredi, MD, FACC, FHRS GHS Cardiovascular Symposium

Basics of Pacing. Ruth Hickling, RN-BSN Tasha Conley, RN-BSN

2/20/2015. Cardiac Evaluation of Potential Solid Organ Transplant Recipients. Issues Specific to Transplantation. Kidney Transplantation.

Treating AF: The Newest Recommendations. CardioCase presentation. Ethel s Case. Wayne Warnica, MD, FACC, FACP, FRCPC

Christopher M. Wright, MD, MBA Pioneer Cardiovascular Consultants Tempe, Arizona

JAPI VOL. 52 NOVEMBER

SIGN. Cardiac arrhythmias in coronary heart disease. Scottish Intercollegiate Guidelines Network. A national clinical guideline

Implantable Cardioverter Defibrillator Treatment: Benefits and Pitfalls in the Currently Indicated Population. Carel Jan Willem Borleffs

Title The Mental Health of Adolescents Living with Potentially Fatal Arrhythmia: A Systematic Review of the Literature

The upper limit of vulnerability (ULV) is the weakest

Piotr Futyma 1*, Marian Futyma 1 and Piotr Kułakowski 1,2

ACCF/SCAI/AATS/AHA/ASE/ASNC/HFSA/HRS/SCCM/SCCT/ SCMR/STS 2012 appropriate use criteria for diagnostic catheterization

How should we treat atrial fibrillation in heart failure

Managing Mitral Regurgitation: Repair, Replace, or Clip? Michael Howe, MD Traverse Heart & Vascular

SPECIALTY : CARDIOLOGY CLINICAL PROBLEM: HEART FAILURE

Steven J. Yakubov, MD FACC For the CoreValve US Clinical Investigators

Tachyarrhythmias (fast heart rhythms)

Reimbursement Information For Electrophysiology and Arrhythmia Service Procedures 1

Cardiac Rehabilitation CARDIAC REHABILITATION HS-091. Policy Number: HS-091. Original Effective Date: 3/16/2009

PRECOMBAT Trial. Seung-Whan Lee, MD, PhD On behalf of the PRECOMBAT Investigators

Cardiac Rehabilitation at AUBMC

CARDIAC NURSING. Graduate Diploma in Nursing Science. Overview. Entry Requirements. Fees. Contact. Teaching Methods.

Michigan Heart & Vascular Institute ON THE ST. JOSEPH MERCY HOSPITAL CAMPUS, ANN ARBOR, MICHIGAN

Non Invasive Testing for CAD

CARDIOMYOPATHY SUPPORT GROUP IRELAND

The Role Of Early Stress Testing In Assessing Low Risk Chest Pain Patients Admitted Through The Emergency Department

Comparison of bipolar and unipolar programmed electrical stimulation for the initiation of ventricular arrhythmias: significance of anodal excitation

Fort Hamilton Hospital Specialty: Cardiology Department of Medicine Delineation of Privileges

Syncope. enough to include disorders such as epileptic seizures and concussion. January 14-15, 2011 SCA Conference 1

50 years of CRM Device Therapy Past, Present and Future. Richard Sutton Professor of Cardiology Imperial College, London, UK

Coronary Artery Disease leading cause of morbidity & mortality in industrialised nations.

Clinical Trials In Cardiac Rhythm Management

Prognostic impact of uric acid in patients with stable coronary artery disease

Cardiac Rehabilitation: Strategies Approaching 2020

Wide-Complex Tachycardias in the ED: Myths and Pitfalls

LEADING-EDGE Cardiovascular Care

Management of Atrial Fibrillation in Heart Failure

Transcription:

Secondary Prevention: CAD VF or Hemodynamically Unstable VT Associated With Acute (<48 h) MI Indication 3 for nonsustained VT 4 days post-mi and inducible VT/VF at EPS 4 days after revascularization is not represented in this figure and was rated as Appropriate for LVEF <50% and May Be Appropriate for LVEF 50%. A = Appropriate; EPS = electrophysiological study; LVEF = left ventricular ejection fraction; M = May Be Appropriate; MI = myocardial infarction; R = Rarely Appropriate; VF = ventricular fibrillation; VT = ventricular tachycardia.

Secondary Prevention: VF or Hemodynamically Unstable VT With No Recent MI and/or No Recent Revascularization A = Appropriate; LVEF = left ventricular ejection fraction; M = May Be Appropriate; MI = myocardial infarction; VF = ventricular fibrillation; VT = ventricular tachycardia.

Secondary Prevention: VF or Hemodynamically Unstable VT No CAD With Structural Heart Disease or Genetic Disorders A = Appropriate; ARVC = arrhythmogenic right ventricular cardiomyopathy; CM = cardiomyopathy; CMVT = catecholaminergic polymorphic ventricular tachycardia; EPS = electrophysiological study; HCM = hypertrophic cardiomyopathy; LVEF = left ventricular ejection fraction; M = May Be Appropriate; MI = myocardial infarction; NICM = nonischemic cardiomyopathy; R = Rarely Appropriate; VF = ventricular fibrillation; VT = ventricular tachycardia.

Secondary Prevention: No Structural Heart Disease (LVEF 50%) or Known Genetic Causes of Sustained VT/VF A = Appropriate; LVEF = left ventricular ejection fraction; M = May Be Appropriate; R = Rarely Appropriate; VF = ventricular fibrillation; VT = ventricular tachycardia; WPW = Wolff-Parkinson-White.

Secondary Prevention: Syncope in Patients Without Structural Heart Disease A = Appropriate; ECG = electrocardiogram; LV = left ventricular; LVEF = left ventricular ejection fraction; R = Rarely Appropriate; RV = right ventricular; VF = ventricular fibrillation; VT = ventricular tachycardia.

Secondary Prevention: Syncope in Patients With Coronary Artery Disease A = Appropriate; EPS = electrophysiological study; LVEF = left ventricular ejection fraction; M = May Be Appropriate; MI = myocardial infarction; R = Rarely Appropriate; VF = ventricular fibrillation; VT = ventricular tachycardia.

Secondary Prevention: Syncope in Patients with Nonischemic Structural Heart Disease A = Appropriate; CM = cardiomyopathy; HCM = hypertrophic cardiomyopathy; LV = left ventricular; LVEF = left ventricular ejection fraction; M = May Be Appropriate; NIDCM = nonischemic dilated cardiomyopathy; R = Rarely Appropriate.

Secondary Prevention: Sustained Hemodynamically Stable Monomorphic VT Associated With Structural Heart Disease A = Appropriate; CAD = coronary artery disease; CM = cardiomyopathy; EPS = electrophysiological study; LVEF = left ventricular ejection fraction; M = May Be Appropriate; MI = myocardial infarction; NICM = nonischemic cardiomyopathy; VT = ventricular tachycardia.

Primary Prevention: Coronary Artery Disease, Post-Acute MI ( 40 Days), LVEF 40% A = Appropriate; EP = electrophysiological; EPS = electrophysiological study; LVEF = left ventricular ejection fraction; M = May Be Appropriate; MI = myocardial infarction; NSVT = nonsustained ventricular tachycardia; R = Rarely Appropriate; VF = ventricular fibrillation; VT = ventricular tachycardia.

Primary Prevention: Coronary Artery Disease, Prior MI (>40 Days) With Ischemic Cardiomyopathy A = Appropriate; CABG = coronary artery bypass graft; CM = cardiomyopathy; EPS = electrophysiological study; LVEF = left ventricular ejection fraction; M = May Be Appropriate; MI = myocardial infarction; NSVT = nonsustained ventricular tachycardia; NYHA = New York Heart Association; PCI = percutaneous coronary intervention; ppm = permanent pacemaker; VF = ventricular fibrillation; VT = ventricular tachycardia.

Primary Prevention: Nonischemic Cardiomyopathy A = Appropriate; CM = cardiomyopathy; dx = diagnosis; GDMT = guideline-directed medical therapy; LVEF = left ventricular ejection fraction; M = May Be Appropriate; NYHA = New York Heart Association; R = Rarely Appropriate.

Primary Prevention: Nonischemic Cardiomyopathy, Specific Etiologies A = Appropriate; CM = cardiomyopathy; LVEF = left ventricular ejection fraction; M = May Be Appropriate; R = Rarely Appropriate.

J Am Coll Association, Cardiol. 2013;61(12):1318-1368. American Society doi:10.1016/j.jacc.2012.12.017 of Echocardiography, Heart Failure Society of America, Society for Primary Prevention: Genetic Conditions (Excludes Syncope and Sustained VT) A = Appropriate; CM = cardiomyopathy; ECG = electrocardiogram; EPS = electrophysiological study; GDMT = guideline-directed medical therapy; LV = left ventricular; LVEF = left ventricular ejection fraction; M = May Be Appropriate; MI = myocardial infarction; NICM = nonischemic cardiomyopathy; NSVT = nonsustained ventricular tachycardia; R = Rarely Appropriate; RV = right ventricular; SCD = sudden cardiac death; VF = ventricular fibrillation; VT = ventricular tachycardia.

Primary Prevention: Comorbidities (Rarely Appropriate Indications) CRT = cardiac resynchronization therapy; HF = heart failure; IV = intravenous; VAD = ventricular assist device.

CRT: No Prior Implant Ischemic Cardiomyopathy A = Appropriate; amb = ambulatory; CRT = cardiac resynchronization therapy; LBBB = left bundle branch block; LVEF = left ventricular ejection fraction; M = May Be Appropriate; NYHA = New York Heart Association; R = Rarely Appropriate.

CRT: No Prior Implant Nonischemic Cardiomyopathy A = Appropriate; amb = ambulatory; CRT = cardiac resynchronization therapy; LBBB = left bundle branch block; LVEF = left ventricular ejection fraction; M = May Be Appropriate; NYHA = New York Heart Association; R = Rarely Appropriate.

CRT: No Prior Implant LVEF >35% of Any Etiology (ICD Indicated) amb = ambulatory; CRT = cardiac resynchronization therapy; ICD = implantable cardioverter-defibrillator; LBBB = left bundle branch block; LVEF = left ventricular ejection fraction; M = May Be Appropriate; NYHA = New York Heart Association; R = Rarely Appropriate.

CRT: No Prior Implant LVEF 35% of Any Etiology (NYHA Class IV on IV Inotropic Support) CRT = cardiac resynchronization therapy; LBBB = left bundle branch block; LVEF = left ventricular ejection fraction; NYHA = New York Heart Association.

J Am Coll Association, Cardiol. 2013;61(12):1318-1368. American Society doi:10.1016/j.jacc.2012.12.017 of Echocardiography, Heart Failure Society of America, Society for CRT: No Prior Implant Pre-Existing or Anticipating RV Pacing With a Clinical Indication for ICD or Pacemaker Implantation A = Appropriate; amb = ambulatory; CRT = cardiac resynchronization therapy; LVEF = left ventricular ejection fraction; M = May Be Appropriate; NYHA = New York Heart Association; R = Rarely Appropriate; RV = right ventricular. Date of download: 4/2/2013 Copyright The American College of Cardiology. All rights reserved.

J Am Coll Association, Cardiol. 2013;61(12):1318-1368. American Society doi:10.1016/j.jacc.2012.12.017 of Echocardiography, Heart Failure Society of America, Society for Refractory Class III/IV Heart Failure <3 Months Post Revascularization and/or 40 Days Post-MI A = Appropriate; LBBB = left bundle branch block; LVEF = left ventricular ejection fraction; M = May Be Appropriate; MI = myocardial infarction; R = Rarely Appropriate. Date of download: 4/2/2013 Copyright The American College of Cardiology. All rights reserved.